Sputum induction in young cystic fibrosis patients

A culture from the lower airway secretions is the optimal sample to guide antibiotic therapy in cystic fibrosis (CF) lung disease. The authors therefore examined whether sputum induction is an efficient, safe and acceptable procedure in CF children without spontaneous expectorations. Nineteen patients were studied. Their mean age (range) was 8.6 yrs (4.3-15.2 yrs). Their mean forced expiratory volume in one second (FEV1) was 88% predicted (46-122%). NaCl solutions from 0.9-6% were inhaled, after baseline lung function tests before and after salbutamol. All patients did produce secretions. Alveolar macrophages were present in 16/19 induced samples. The procedure induced minor but significant bronchoconstriction: the mean change (range) in postsalbutamol FEV1 (% pred) was -7 (-24-16). Percutaneous oxygen saturation remained above 90% in all children. The test had to be discontinued in one child because of cough and wheeze. Acceptability of the procedure evaluated using a visual analogue scale from -7-7 showed a mean value (range) at the final concentration of -1.23 (-6.16-5.88). It is concluded that sputum induction is possible, safe and acceptable in cystic fibrosis children who do not expectorate spontaneously.

This article has been cited by other articles:

				H. Mussaffi, E. M. Fireman, M. Mei-Zahav, D. Prais, and H. Blau Induced Sputum in the Very Young: A New Key to Infection and Inflammation Chest, January 1, 2008; 133(1): 176 - 182. [Abstract] [Full Text] [PDF]

				D. K. Radhakrishnan, M. Corey, and S. D. Dell Realities of Expectorated Sputum Collection in the Pediatric Cystic Fibrosis Clinic Arch Pediatr Adolesc Med, June 1, 2007; 161(6): 603 - 606. [Abstract] [Full Text] [PDF]

				C. H Goss and J. L Burns Exacerbations in cystic fibrosis {middle dot} 1: Epidemiology and pathogenesis Thorax, April 1, 2007; 62(4): 360 - 367. [Abstract] [Full Text] [PDF]

				C. L. Ordonez, N. R. Henig, N. Mayer-Hamblett, F. J. Accurso, J. L. Burns, J. F. Chmiel, C. L. Daines, R. L. Gibson, S. McNamara, G. Z. Retsch-Bogart, et al. Inflammatory and Microbiologic Markers in Induced Sputum after Intravenous Antibiotics in Cystic Fibrosis Am. J. Respir. Crit. Care Med., December 15, 2003; 168(12): 1471 - 1475. [Abstract] [Full Text] [PDF]

				N. Reinhardt, C.I.U. Chen, D. Loppow, T. Schink, I. Kleinau, R.A. Jorres, U. Wahn, H. Magnussen, and K.P. Paul Cellular profiles of induced sputum in children with stable cystic fibrosis: comparison with BAL Eur. Respir. J., September 1, 2003; 22(3): 497 - 502. [Abstract] [Full Text] [PDF]

				M. L. Aitken, K. E. Greene, M. R. Tonelli, J. L. Burns, J. C. Emerson, C. H. Goss, and R. L. Gibson Analysis of Sequential Aliquots of Hypertonic Saline Solution-Induced Sputum From Clinically Stable Patients With Cystic Fibrosis Chest, March 1, 2003; 123(3): 792 - 799. [Abstract] [Full Text] [PDF]

				A. Jung, I. Kleinau, G. Schonian, A. Bauernfeind, C. Chen, M. Griese, G. Doring, U. Gobel, U. Wahn, and K. Paul Sequential genotyping of Pseudomonas aeruginosa from upper and lower airways of cystic fibrosis patients Eur. Respir. J., December 1, 2002; 20(6): 1457 - 1463. [Abstract] [Full Text] [PDF]

				S. D. SAGEL, R. KAPSNER, I. OSBERG, M. K. SONTAG, and F. J. ACCURSO Airway Inflammation in Children with Cystic Fibrosis and Healthy Children Assessed by Sputum Induction Am. J. Respir. Crit. Care Med., October 15, 2001; 164(8): 1425 - 1431. [Abstract] [Full Text] [PDF]

				J.A. Kastelik, I. Aziz, and A.H. Morice Sputum induction in young cystic fibrosis patients Eur. Respir. J., April 1, 2001; 17(4): 832 - 832. [Full Text] [PDF]